英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
palatin查看　palatin　在百度字典中的解释百度英翻中〔查看〕
palatin查看　palatin　在Google字典中的解释Google英翻中〔查看〕
palatin查看　palatin　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Palatin Technologies | Home
    Palatin delivers treatments that Harness the healing power of the melanocortin system We discover and develop novel therapeutics for patients living with inflammatory and autoimmune conditions
  • Palatin Technologies | Pipeline
    Demonstrated leader in the discovery and development of melanocortin agonist treatments
  • Palatin Technologies | About Us
    Our therapeutics provide a novel approach that allows affected tissue time to heal
  • Palatin Technologies | Press Releases
    Press releases issued by Palatin are accessible below These press releases contain additional information about our business, clinical trial developments, research and development activities, financial achievements, and strategic partnerships
  • Palatin Technologies | Investors
    Palatin’s actual results may differ materially from those discussed in the forward-looking statements for various reasons, including but not limited to our ability to fund development of our technology, our ability to establish and successfully complete clinical trials and preclinical studies, and the results of those trials and studies
  • Palatin Technologies | Our Science
    Our current focus is on the design and development of receptor selective melanocortin agonists for inflammation and autoimmune conditions, with a focus on ocular diseases Our therapeutics work by activating endogenous melanocortin pathways to resolve damaging inflammation and allow affected tissues time to heal Research has shown melanocortin agonists can prevent and reverse inflammation in
  • Palatin Technologies | SEC Filings
    Investors SEC Filings
  • Palatin Presents Data at ObesityWeek® 2025 Highlighting Promise of . . .
    About Palatin Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential
  • Palatins Oral MC4R Agonist PL7737 Receives FDA Orphan Drug Designation . . .
    About Palatin Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential
  • Palatin Reports Positive Appetite Suppression Results From Phase 2 . . .
    CRANBURY, N J , April 17, 2025 PRNewswire — Palatin Technologies, Inc (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, announced positive appetite suppression results from its BMT-801 Phase 2 obesity study





中文字典-英文字典  2005-2009